Pfizer working for a healthier Vietnam
  • | vneconomictimes | December 10, 2017 10:12 AM
Biopharmaceutical firm supporting Vietnamese children with heart disease and providing scholarships to local students.

By financially supporting the Heart Institute in Vietnam, Pfizer, one of the world’s premier biopharmaceutical companies, has recently helped underprivileged Vietnamese children who come from indigent families receive cardiac surgeries so they can live a healthier life. Pfizer also builds for the future by recently presenting ten scholarships to the best medical students in Ho Chi Minh City and Hanoi.

According to the Ministry of Health, approximately 8,000 to 10,000 children suffer from congenital heart disease in Vietnam but only around half undergo surgery, while the remainder wait for the chance to undergo surgery, with some dying before being diagnosed and receiving treatment. The cost of surgery is the biggest obstacle preventing children who suffer from heart disease from enjoying a normal life.

Pfizer financially supports the Heart Institute in carrying out cardiac surgeries for child patients, in the hope of easing their pain, giving them a new and better life, and helping them jumpstart a brighter future.

The Heart Institute, established in 1992 by Professor Alain Carpentier and Dr. Duong Quang Trung, is a non-profit institute. For the past 20 years, the lives of more than 5,000 underprivileged children have been saved thanks to the help of the Heart Institute and the generosity of donors like Pfizer.

Pfizer started its scholarship program in Vietnam with the help of the Thailand Pfizer Fund in 2006. Every year, freshmen medical students with excellent academic performance have the chance to receive scholarships that will help them continue their studies and eventually help enhance their community’s health.

So far, Pfizer has supported 13 top-notch medical students throughout their university days and witnessed their growth and maturity. The students chosen to be in scholarship program all achieved merit graduation status.

This has motivated Pfizer to continue pursuing its mission of building for the future. This is further evident from Pfizer awarding ten scholarships to top students at the Ho Chi Minh City Medicine and Pharmacy University and the Hanoi Medical University in November.

According to the Ministry of Health, non-communicable diseases (NCD) such as high blood pressure, diabetes, cardiovascular disease, mental illness, and cancer are responsible for 75 per cent of mortality and are becoming one of leading causes of death in Vietnam. Pfizer is committed to collaborating with partners to design NCD-preventive programs via knowledge sharing and awareness enhancement for medical staff and the community.

In 2017, Pfizer partnered with the international non-profit organization Population Services International (PSI) to announce Healthy Communities, a $1 million collaboration to expand access to life-saving hypertension medicines and treatment services in Myanmar and Vietnam.

“Building for the future as well as taking care of the health of children and communities is one of the main pillars of community contribution that Pfizer is doing to realize our goal ‘For a Healthier Vietnam’,” said Mr. Bradley Allen Silcox from Pfizer Thailand in Vietnam. “We highly appreciate our collaboration with our partners and take pride in contributing to improving the lives of Vietnamese patients.”

Pfizer is committed to applying science and its global resources to improve health and well-being at every stage of life. In 2016, it invested over $7 billion in research and development (R&D).

Leave your comment on this story